1. Adherence to dual anti-platelet therapy after acute coronary syndrome and its impact on patient outcome. (25th November 2020) Authors: Sulzgruber, P; Sinkovec, H; Kazem, N; Hofer, F; Hammer, A; Koller, L; Todorovic, M; Katsch, F; Gall, W; Duftschmid, G; Heinze, G; Niessner, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19). (14th October 2021) Authors: Santoro, F; Vitale, E; Nunez Gil, I; Guerra, F; El-Battrawy, I; Brunetti, N D Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Aspirin vs. P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation: insights from the AFIRE trial. (14th October 2021) Authors: Fukaya, H; Ako, J; Yasuda, S; Kaikita, K; Akao, M; Matoba, T; Nakamura, M; Miyauchi, K; Hagiwara, N; Kimura, K; Hirayama, A; Matsui, K; Ogawa, H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Benefit and risks of extended dual antiplatelet therapy beyond 1 year in high-risk patients after drug-eluting stent implantation. (25th November 2020) Authors: Wang, H; Gao, R; Yang, Y; Xu, B.O; Dou, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cilostazol improves hyperglycemia-induced impaired vasculo-angiogenesis through stimulating adiponectin/adiponectin receptor 1/Sirtuin 1 signaling pathway. (25th November 2020) Authors: Chao, T.H; Tseng, S.Y; Li, Y.H Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparing clinical outcomes following 1 year of dual antiplatelet therapy in patients risk stratified by the PRECISE-DAPT and DAPT scores. (25th November 2020) Authors: Boudreau, R; Fu, A; Barry, Q; Tran, U; Perry-Nuygen, D; Simard, T; Le May, M; Labinaz, L; Dick, A; Glover, C; Froeschl, M; Hibbert, B; Chong, A; So, D Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Differences of gastrointestinal bleeding after percutaneous coronary intervention with stent implantation among the different dual anti platelet therapies. (14th October 2021) Authors: Idiazabal, U; Ruiz Rodriguez, A; Pereiro Lili, I; Diez Gonzalez, I; Atucha Salazar, A; Amuriza De Luis, E; Gorostiza Hormaetxe, I; Pascual Serrano, J J; Aguirrezabal Arredondo, A; Ormaetxe Merodio, J M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dual antiplatelet therapy with 3rd generation P2Y12 inhibitors in STEMI patients: impact of Body Mass Index on high on-treatment platelet reactivity. (14th October 2021) Authors: Scudiero, F; Canonico, M E; Sanna, G D; Saba, P G; Esposito, G; Parodi, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease. (14th October 2021) Authors: Galli, M; Capodanno, D; D'Amario, D; Andreotti, F; Crea, F; Angiolillo, D J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of early aspirin withdrawal and continuation of ticagrelor monotherapy post PCI for STEMI. A post hoc analysis of the randomized global leaders trial. (14th October 2021) Authors: Gamal Setih, A; Hara, H; Tomaniak, M; Lunardi, M; Gao, C; Ono, M; Kawashima, H; Juni, P; Vranckx, P; Windecker, S; Hamm, C; Gabriel Steg, P; Onuma, Y; Serruys, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗